Peer Review reports
From: Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer
Original Submission | ||
---|---|---|
12 Mar 2021 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
21 Mar 2021 | Reviewed | Reviewer Report |
1 Apr 2021 | Reviewed | Reviewer Report |
11 Apr 2021 | Author responded | Author comments - Mei-Jin Huang |
Resubmission - Version 3 | ||
11 Apr 2021 | Submitted | Manuscript version 3 |
12 Apr 2021 | Author responded | Author comments - Mei-Jin Huang |
Resubmission - Version 4 | ||
12 Apr 2021 | Submitted | Manuscript version 4 |
13 Apr 2021 | Author responded | Author comments - Mei-Jin Huang |
Resubmission - Version 5 | ||
13 Apr 2021 | Submitted | Manuscript version 5 |
14 Apr 2021 | Author responded | Author comments - Mei-Jin Huang |
Resubmission - Version 6 | ||
14 Apr 2021 | Submitted | Manuscript version 6 |
17 Apr 2021 | Reviewed | Reviewer Report |
30 Apr 2021 | Reviewed | Reviewer Report |
4 May 2021 | Author responded | Author comments - Mei-Jin Huang |
Resubmission - Version 7 | ||
4 May 2021 | Submitted | Manuscript version 7 |
5 May 2021 | Author responded | Author comments - Mei-Jin Huang |
Resubmission - Version 8 | ||
5 May 2021 | Submitted | Manuscript version 8 |
13 May 2021 | Reviewed | Reviewer Report |
Resubmission - Version 9 | ||
Submitted | Manuscript version 9 | |
Publishing | ||
19 May 2021 | Editorially accepted | |
18 Jun 2021 | Article published | 10.1186/s12893-021-01273-5 |
You can find further information about peer review here.